FDAnews
www.fdanews.com/articles/108911-depomed-rsquo-s-proquin-xr-achieves-first-marketing-authorization-in-europe

Depomed’s ProQuin XR Achieves First Marketing Authorization in Europe

July 25, 2008
Depomed, Inc. and Rottapharm/Madaus announced that the Marketing Authorization for ProQuin XR has been received from the Medical Products Agency in Sweden.
Fox Business